Aktie USNU U.S. NEUROSURGICAL HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen U.S. NeuroSurgical Holdings, Inc.

Aktien

USNU

US90336K1016

USNU

Markt geschlossen - OTC Markets
Andere Börsenplätze
 17:26:19 29.04.2024 		% 5 Tage % 1. Jan.
0,72 USD +1,41 % Intraday Chart für U.S. NeuroSurgical Holdings, Inc. +1,41 % +60,00 %
05.04. U.S. NeuroSurgical Holdings, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 U.S. NeuroSurgical Holdings, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
U.S. NeuroSurgical Holdings, Inc. announced that it expects to receive $2 million in funding
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
U.S. NEUROSURGICAL HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
U.S. NeuroSurgical Holdings, Inc. Appoints William St. Lawrence as a Non-Executive Director
U.S. NEUROSURGICAL HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
U.S. NEUROSURGICAL HOLDINGS, INC. Management Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
U.S. NEUROSURGICAL HOLDINGS, INC. - 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.
U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
U.S. NEUROSURGICAL HOLDINGS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. USNU Aktie
  4. Nachrichten U.S. NeuroSurgical Holdings, Inc.
  5. Andere Sprachen